Dr. Bruce Minsky, MD

• Radiation Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Massachusetts / Boston Campus

  Medical School, 1982

• Impact of tumor regression grade on recurrence after preoperative chemoradiation and gastrectomy for gastric cancer, 2020-05-27

• Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials, 2023-05-17

• The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy, 2020-09-07

• Chemotherapy versus Chemotherapy plus Chemoradiation as Preoperative Therapy for Resectable Gastric Adenocarcinoma: A Propensity Score-Matched Analysis of a Large Single-Institution Experience, 2020-07-21

• Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma, 2018-08-27

• HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development, 2023-03-29

• The proportion of signet ring cell component in patients with localized gastric adenocarcinoma correlates with the degree of response to preoperative chemoradiation, 2016-04-06

• Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer, 2016-06-23

• Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma, 2021-12-01

• Impact factor and citation metrics in phase III cancer trials, 2021-08-31

• The ypT category does not impact overall survival in node negative gastric cancer, 2018-06-27

• Performance Status Restriction in Phase III Cancer Clinical Trials, 2020-10-01

• Nodal Downstaging in Gastric Cancer Patients: Promising Survival if ypN0 is Achieved, 2018-05-10

• Food and Drug Administration approvals in phase 3 Cancer clinical trials, 2021-06-12

• Laparoscopic HIPEC for low-volume peritoneal metastasis in gastric and gastroesophageal adenocarcinoma, 2020-07-31

• Association of Medicaid Insurance With Survival Among Patients With Small Cell Lung Cancer Association of Medicaid Insurance With Survival Among Patients With Small Cell Lung Cancer, 2020-04-22

• Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial, 2022-09-12

• Treatment Patterns for Gastroesophageal Junction Adenocarcinoma in the United States†, 2020-10-29

• Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic Cancer, 2022-05-26

• Concurrent lymphovascular and perineural invasion after preoperative therapy for gastric adenocarcinoma is associated with decreased survival, 2021-01-05

• Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials, 2020-09-16

• Repeat staging laparoscopy for gastric cancer after preoperative therapy, 2018-06-07

• Low metabolic activity in primary gastric adenocarcinoma is associated with resistance to chemoradiation and the presence of signet ring cells, 2020-05-14

• Ablative Liver Radiotherapy for Unresected Intrahepatic Cholangiocarcinoma: Patterns of Care and Survival in the United States, 2022-04-13

• Progression-Free Survival is a Suboptimal Predictor for Overall Survival Among Metastatic Solid Tumor Clinical Trials, 2020-07-20

• Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal Cancer, 2021-10-09

• Relationship between Initial Management Strategy and Survival in Patients with Gastric Outlet Obstruction due to Gastric Cancer, 2020-08-18

• New Strategies in Radiation Therapy: Exploiting the Full Potential of Protons, 2013-09-27

• Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma, 2019-01-16

• CEA as a blood-based biomarker in anal cancer, 2021-05-25

• Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution, 2022-01-28

• Hyperfractionated abdominal reirradiation for gastrointestinal malignancies, 2018-08-07

• Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma, 2020-02-17

• Dosimetric uncertainties resulting from interfractional anatomic variations for patients receiving pancreas stereotactic body radiation therapy and cone-beam CT image guidance, 2021-08-13

• Assessment of setup uncertainty in hypofractionated liver radiation therapy with a breath-hold technique using automatic image registration-based image guidance, 2019-08-30

• Comparison of locoregional versus extended locoregional radiation volumes for patients with non-metastatic gastro-esophageal junction carcinomas, 2015-01-04

• The Radiotherapy Quality Assurance Gap Among Phase III Cancer Clinical Trials, 2021-11-25

• CHEMOTHERAPY VERSUS CHEMOTHERAPY PLUS CHEMORADIATION AS NEOADJUVANT THERAPY FOR RESECTABLE GASTRIC ADENOCARCINOMA: A MULTI-INSTITUTIONAL ANALYSIS, 2021-10-01